Marinus Pharmaceuticals (NASDAQ:MRNS) Coverage Initiated at StockNews.com
Investment analysts at StockNews.com started coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also commented on MRNS. Jefferies Financial Group reissued a “hold” rating and issued […]
Investment analysts at StockNews.com started coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. A number of other equities analysts have also commented on MRNS. Jefferies Financial Group reissued a “hold” rating and issued […]
